Patient completion of screening tests (lipids - cardiovascular disease risk) | HQCA Focus

Healthcare Areas

Also in this section
primary icon

Primary Healthcare

Patient completion of screening tests (lipids – cardiovascular disease risk)

Percentage of eligible patients who received screening for cardiovascular disease risk (lipids) (see data definition). Please note that 2019-22 data for lipids screening is not available.

*Data courtesy of Alberta Health Services and Alberta Health

Please note that due to a technical issue, 2019-22 data are currently not available for lipids screening. The current display for these charts shows 2018-19 data, and will be updated once new data is available.

What do you see?

  • Are there geographic differences in screening rates? For example, are there differences in screening rates in rural areas compared to urban?
  • What are some of the reasons that patients may not get the recommended screening?
  • Are there any differences in completion rates for the various screening tests? What are some factors that could account for this?

Understanding patient completion of screening tests

Doctors order screening tests to help with early detection of diseases in patients who they know are at risk of that disease, either because of family history or other factors such as age, gender or lifestyle. Established guidelines for screening can be found from the Alberta Screening and Prevention program. Early detection of disease is important because early treatment can reduce long term complications and improve outcomes and overall quality of care for patients.

Screening rates are an important measure of quality of care. The percentage of eligible Albertans (i.e., those most likely to benefit from the test) who receive screening tests is affected by the actions of both doctors and patients. Doctors must offer screening to their patients, and patients must follow-through by going to the lab (e.g., for diabetes and lipid screening) or making and attending an appointment for certain types of tests (e.g., mammogram for breast cancer screening or colonoscopy for colorectal cancer screening).

Considerations when reviewing the results

  • The information shows the percentage of patients who completed a screening test, not how many were offered a screening test.
  • There are many factors that affect the rate of completed screening tests. This includes how often doctors offer the screening tests, patient acceptability and willingness to follow-through with a screening test, and availability of certain screening tests in some areas of the province.

Information about lipid testing for cardiovascular disease

Screening for diseases that are related to abnormal lipids is done using a blood test that measures the levels of different kinds of lipids (fats) in the patient’s blood. This test is used with other information about the patient such as age, gender, blood pressure, smoking status and family history to determine the patient’s level of risk for heart disease and stroke. The current guidelines used in Alberta for lipid screening are available here:

Alberta Quality Matrix for Health

The Health Quality Council of Alberta uses the Alberta Quality Matrix for Health as a way of organizing information and thinking around the complexity of the healthcare system. This measure can be used as input to assess primary healthcare’s performance in these dimensions of quality: Acceptability, Appropriateness, Effectiveness, and Safety.